Decoy Therapeutics is trading at $4.27 (9% up) in after-hours trading as the stock extends a rebound triggered by positive July 28 lab results for its Ebola Zaire platform.
- The move follows a 5.7% after-hours gain on July 29, with the stock having closed the July 30 regular session at $3.92.
- No new company-specific headlines have emerged to explain the latest leg up, though broader markets are also trading firmly higher.